\chapter{Included Trials}\label{trialData}

This appendix presents the trial data for each trial included in this study. It should be noted that due to having to digitise the survival data, as opposed to having IPD, there may be some slight discrepencies between the numbers presented here, and in the original publications. Table~\ref{hrtable} presents the hazard ratios

\begin{table}[h]
    \center
    \begin{tabular}{llllll}
    \hline
    Study      & Comparator & HR     & L95    & U95    & Time (Months) \\ \hline
    Colucci    & GEM+CIS    & 1.0746 & 0.8729 & 1.3227 & 36 \\
    Cunningham & GEM+CAP    & 0.8249 & 0.6928 & 0.9820 & 27 \\
    Kindler    & GEM+AXI    & 1.0606 & 0.8132 & 1.3835 & 13 \\
    Oettle     & GEM+PEM    & 0.9826 & 0.8186 & 1.1796 & 24 \\
    RochaLima  & GEM+IRI    & 1.0365 & 0.8305 & 1.2936 & 30 \\ \hline
    \end{tabular}
    \caption{Hazard ratios for each study}
    \label{hrtable}
    \end{table}
\section{Colucci, 2010}
The Colucci et. al study~\cite{colucci2010} compared Gemcitabine plus Cistplatin (GEM+CIS) with Gemcitabine (GEM) in a total of 400 patients. 

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/Colucci.png}
    \caption{Colucci 2010 KM Curve}
    \label{col2010km}
\end{figure}

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/Colucci_CumHaz.png}
    \caption{Colucci 2010 Cumulative Hazard}
    \label{col2010ch}
\end{figure}

\newpage

\section{Cunningham, 2009}
The Cunningham et. al study~\cite{cunningham2009} compared Gemcitabine plus Capecitabine (GEM+CAP) with Gemcitabine (GEM) in a total of 533 patients. 

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/Cunningham.png}
    \caption{Cunningham 2009 KM Curve}
    \label{cun2009km}
\end{figure}

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/Cunningham_CumHaz.png}
    \caption{Cunningham 2009 Cumulative Hazard}
    \label{cun2009ch}
\end{figure}

\newpage

\section{Kindler, 2011}
The Cunningham et. al study~\cite{kindler2011} compared Gemcitabine plus Axitinib (GEM+AXI) with Gemcitabine (GEM) in a total of 632 patients. 

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/Kindler.png}
    \caption{Kinder 2011 KM Curve}
    \label{kin2011km}
\end{figure}

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/Kindler_CumHaz.png}
    \caption{Kinder 2011 Cumulative Hazard}
    \label{kin2011ch}
\end{figure}

\newpage

\section{Oettle, 2005}
The Cunningham et. al study~\cite{oettle2005} compared Gemcitabine plus Pemetrexed (GEM+PEM) with Gemcitabine (GEM) in a total of 565 patients. 

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/Oettle.png}
    \caption{Oettle 2005 KM Curve}
    \label{kin2005km}
\end{figure}

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/Oettle_CumHaz.png}
    \caption{Oettle 2005 Cumulative Hazard}
    \label{kin2005ch}
\end{figure}

\newpage

\section{Rocha Lima, 2004}
The Cunningham et. al study~\cite{rocha2004} compared Gemcitabine plus Irinotecan (GEM+IRI) with Gemcitabine (GEM) in a total of 360 patients. 

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/RochaLima.png}
    \caption{Rocha Lima 2004 KM Curve}
    \label{rl2004km}
\end{figure}

\begin{figure}
    \center
    \includegraphics[width = 0.9\textwidth]{../figures/KMs/Oettle_CumHaz.png}
    \caption{Rocha Lima 2004 Cumulative Hazard}
    \label{rl2004ch}
\end{figure}
